Barriers to application of genetically modified lactic acid bacteria

被引:7
|
作者
Verrips, CT
vandenBerg, DJC
机构
[1] Unilever Research Laboratorium Vlaardingen, 3133 AT Vlaardingen
关键词
lactic acid bacteria; rDNA technology; risk assessment and consumer acceptance;
D O I
10.1007/BF00395938
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To increase the acceptability of food products containing genetically modified microorganisms it is necessary to provide in an early stage to the consumers that the product is safe and that the product provide a clear benefit to the consumer. To comply with the first requirement a systematic approach to analyze the probability that genetically modified lactic acid bacteria will transform other inhabitants of the gastro- intestinal (G/I) tract or that these lactic acid bacteria will pick up genetic information of these inhabitants has been proposed and worked out to some degree. From this analysis it is clear that reliable data are still missing to carry out complete risk assessment. However, on the basis of present knowledge, lactic acid bacteria containing conjugative plasmids should be avoided. Various studies show that consumers in developed countries will accept these products when they offer to them health or taste benefits or a better keepability. For the developing countries the biggest challenge for scientists is most likely to make indigenous fermented food products with strongly improved microbiological stability due to broad spectra bacteriocins produced by lactic acid bacteria. Moreover, these lactic acid bacteria may contribute to health.
引用
收藏
页码:299 / 316
页数:18
相关论文
共 50 条
  • [1] Safety Aspects of Genetically Modified Lactic Acid Bacteria
    Plavec, Tina Vida
    Berlec, Ales
    [J]. MICROORGANISMS, 2020, 8 (02)
  • [2] Safety aspects of genetically modified lactic acid bacteria
    Hammes, WP
    Hertel, C
    Cavadini, C
    [J]. GENETICALLY MODIFIED FOODS: SAFETY ISSUES, 1995, 605 : 181 - 194
  • [3] Mucosal Vaccination and Therapy with Genetically Modified Lactic Acid Bacteria
    Wells, Jerry
    [J]. ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 2, 2011, 2 : 423 - 445
  • [4] SAFETY ASPECTS OF GENETICALLY-MODIFIED LACTIC-ACID BACTERIA
    HAMMES, WP
    HERTEL, C
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 40 - AGFD
  • [5] Biosafety aspects of genetically modified lactic acid bacteria in EU legislation
    Lindgren, I
    [J]. INTERNATIONAL DAIRY JOURNAL, 1999, 9 (01) : 37 - 41
  • [6] Genetically modified lactic acid bacteria: applications to food or health and risk assessment
    Renault, P
    [J]. BIOCHIMIE, 2002, 84 (11) : 1073 - 1087
  • [7] Immunomodulation by genetically engineered lactic acid bacteria
    Van Huynegem, Karolien
    Loos, Michaela
    Steidler, Lothar
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 4825 - 4835
  • [8] Risk Assessment of Genetically Modified Lactic Acid Bacteria Using the Concept of Substantial Equivalence
    Guy LeBlanc, Jean
    Van Sinderen, Douwe
    Hugenholtz, Jeroen
    Piard, Jean-Christophe
    Sesma, Fernando
    Savoy de Giori, Graciela
    [J]. CURRENT MICROBIOLOGY, 2010, 61 (06) : 590 - 595
  • [9] Risk Assessment of Genetically Modified Lactic Acid Bacteria Using the Concept of Substantial Equivalence
    Jean Guy LeBlanc
    Douwe Van Sinderen
    Jeroen Hugenholtz
    Jean-Christophe Piard
    Fernando Sesma
    Graciela Savoy de Giori
    [J]. Current Microbiology, 2010, 61 : 590 - 595
  • [10] Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update
    Guy LeBlanc, Jean
    Aubry, Camille
    Cortes-Perez, Naima G.
    de Moreno de LeBlanc, Alejandra
    Vergnolle, Nathalie
    Langella, Philippe
    Azevedo, Vasco
    Chatel, Jean-Marc
    Miyoshi, Anderson
    Bermudez-Humaran, Luis G.
    [J]. FEMS MICROBIOLOGY LETTERS, 2013, 344 (01) : 1 - 9